Soleno Therapeutics (SLNO) Shares Outstanding (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Shares Outstanding (Entity) of $51.7 million for Q1 2026, up 6.57% year-over-year from $48.5 million in Q1 2025, and down 1.09% quarter-over-quarter from $52.3 million in Q4 2025.
Soleno Therapeutics (SLNO) Shares Outstanding (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Shares Outstanding (Entity) for 14 consecutive years, with $51.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 6.57% year-over-year to $51.7 million; the TTM figure through Mar 2026 stood at $51.7 million (up 6.57% YoY), while the FY2025 annual figure was $52.3 million, up 14.4% from the prior year.
- Shares Outstanding (Entity) slipped to $51.7 million in Q1 2026 per SLNO's latest filing, from $52.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $53.7 million in Q3 2025 and bottomed at $5.3 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $28.9 million across 5 years, with a median of $33.3 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 0.37% — and 2024, when it soared 308.1%.
- Soleno Therapeutics' Shares Outstanding (Entity) stood at $8.2 million in 2022, then soared by 102.12% to $16.5 million in 2023, then soared by 177.12% to $45.7 million in 2024, then advanced by 14.4% to $52.3 million in 2025, then decreased by 1.09% to $51.7 million in 2026.
- Business Quant data shows SLNO's Shares Outstanding (Entity) at $51.7 million in Q1 2026, $52.3 million in Q4 2025, and $53.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 52.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.09 Mn |
| Dec 31, 2025 | 50.82 Mn |
| Sep 30, 2025 | 53.33 Mn |
| Jun 30, 2025 | 50.48 Mn |
| Mar 31, 2025 | 46.18 Mn |
| Dec 31, 2024 | 40.18 Mn |
| Sep 30, 2024 | 41.88 Mn |
| Jun 30, 2024 | 38.63 Mn |
| Mar 31, 2024 | 36.21 Mn |
| Dec 31, 2023 | 16.49 Mn |
| Sep 30, 2023 | 11.44 Mn |
| Jun 30, 2023 | 10.42 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 8.09 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 5.33 Mn |
| Dec 31, 2021 | 5.32 Mn |
| Sep 30, 2021 | 5.32 Mn |
| Jun 30, 2021 | 5.32 Mn |